Analysts have revised Scilex Holding's forecasts negatively, cutting revenue and EPS estimates. Despite a recent stock price increase, demand impact remains uncertain. Revenue growth is expected to accelerate, surpassing industry growth rates. Loss per share estimates have increased, while revenue estimates were downgraded.